Most recent report: Internet-related - Amazon.com Inc. (AMZN)

VC Private Financings

A10 Networks raises $23,000,000

A10 Networks, the technology leader in providing Web Application Delivery solutions, today announced the completion of $23 million in Series C funding.  A10 Networks was founded in Q4 2004 with a mission to provide innovative networking and security solutions. A10 Networks makes high-performance products that help organizations accelerate, optimize and secure their applications.  Since the […]

Arisdyne Systems raises $5,300,000

Arisdyne Systems Inc., an alternative fuel, cavitation technology and equipment company headquartered in Cleveland, recently raised $5.3 million in new equity financing to facilitate research on biofuel production methods.  The company is now well positioned to expand research in biofuels by exploring related technologies as well as processing non-food feedstocks. Additionally, more resources can now […]

CardioKinetix raises $14,500,000

CardioKinetix Inc., a Redwood City, Calif.-based heart failure treatment company, secured $14.5 million in Series C funding.  CardioKinetix, Inc. develops technology for the treatment of congestive heart failure. The company offers medical implants that treat ventricular wall motion abnormalities, which occur after an AMI and can progress to end-stage heart failure.

Collegium Pharmaceutical raises $20,000,000

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has closed a $20 million Series D equity financing.  Collegium is focused on building a portfolio of pain products that incorporate its patent protected DETERx formulation platform that provides for sustained release and tamper resistance. The Company also through its subsidiary, Onset Therapeutics develops […]

Dicerna Pharmaceuticals raises $8,400,000

Dicerna Pharmaceuticals, Inc., an RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology, today announced a second closing of its Series A financing, receiving a total of $8.4 million in additional venture capital.  Dicerna announced its strategic focus in the therapeutic areas of oncology, metabolic diseases and hepatitis C infection (HCV).  “Dicerna’s platform […]

Golden Gate raises $2,600,000

Golden Gate Trade Services Joint Stock Committee has secured $2.6 million from Vietnam investment firm Mekong Capital. The investment is the firm’s seventh from its second fund. Golden Gate operates hotpot restaurants under the name Ashima in Ho Chi Minh City, Hanoi, and Hai Phong.

NeoSaej raises $7,000,000

NeoSaej Corporation, a leader in online auction marketplaces and developer of MoneyAisle.com, the first and only Web site where banks competitively bid for customers through live secure auctions, today announced it had closed $7 million in funding.  MoneyAisle is the next-generation e-commerce auction marketplace that provides consumers with great rates on CDs and high-yield savings […]

ON24 raises $8,000,000

ON24, Inc., the global leader in webcasting and virtual events solutions, announced that it has secured over $8 million in equity and expansion capital financing.  ON24 continues to experience strong customer and sales momentum, with over 40% sales growth year over year. Enterprises, business-to-business publishers, government, and life science organizations worldwide overwhelmingly select ON24 for […]

Sojern raises $16,000,000

Sojern, an airline ad startup, raised $16 million in its first round of funding.  “Working with airlines, Sojern brings customized, destination-oriented content to travelers throughout their trip. Along the way, we create rich opportunities for advertisers to connect with customers in powerful ways. It starts with a boarding pass.  Every day, businesses are discovering new […]

SuppreMol raises $25,000,000

SuppreMol GmbH, a German biopharmaceutical company developing novel therapeutics for the treatment of autoimmune diseases closed a 15.7 Euro ($25 million) million Series B financing round.  “In particular the Company is focused on the development of soluble Fc?-Receptors (sFcRs) which are recombinant autologous therapeutic proteins endowed with a proven strong immunosuppressive potential. SuppreMol will develop […]